Skip to main content

Pfizer’s stock drops as earnings fall sharply amid lower sales for its COVID products

Pfizer's stock was down premarket as earnings hit by lower demand for its COVID products.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.